Celebrex Labeling For Polyps Should Emphasize Adjunctive Role, Cmte. Says

Searle's Celebrex labeling for reduction of adenomatous colorectal polyps should emphasize monitoring and urge surgery when needed, FDA's Oncologic Drugs Advisory Committee suggested at its Dec. 14 meeting.

More from Archive

More from Pink Sheet